These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 10587263)
1. Treatment of canine mast cell tumors with CCNU (lomustine). Rassnick KM; Moore AS; Williams LE; London CA; Kintzer PP; Engler SJ; Cotter SM J Vet Intern Med; 1999; 13(6):601-5. PubMed ID: 10587263 [TBL] [Abstract][Full Text] [Related]
2. CCNU in the treatment of canine epitheliotropic lymphoma. Williams LE; Rassnick KM; Power HT; Lana SE; Morrison-Collister KE; Hansen K; Johnson JL J Vet Intern Med; 2006; 20(1):136-43. PubMed ID: 16496933 [TBL] [Abstract][Full Text] [Related]
4. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719 [TBL] [Abstract][Full Text] [Related]
5. Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004). Risbon RE; de Lorimier LP; Skorupski K; Burgess KE; Bergman PJ; Carreras J; Hahn K; Leblanc A; Turek M; Impellizeri J; Fred R; Wojcieszyn JW; Drobatz K; Clifford CA J Vet Intern Med; 2006; 20(6):1389-97. PubMed ID: 17186855 [TBL] [Abstract][Full Text] [Related]
6. A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors. Grant IA; Rodriguez CO; Kent MS; Sfilgoi G; Gordon I; Davis G; Lord L; London CA J Vet Intern Med; 2008; 22(2):388-93. PubMed ID: 18312556 [TBL] [Abstract][Full Text] [Related]
7. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours. Rassnick KM; Bailey DB; Russell DS; Flory AB; Kiselow MA; Intile JL; Malone EK; Balkman CE; Barnard SM Vet Comp Oncol; 2010 Jun; 8(2):138-52. PubMed ID: 20579327 [TBL] [Abstract][Full Text] [Related]
8. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07). Heading KL; Brockley LK; Bennett PF Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164 [TBL] [Abstract][Full Text] [Related]
9. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005). Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534 [TBL] [Abstract][Full Text] [Related]
10. Phase I evaluation of CCNU (lomustine) in tumor-bearing cats. Rassnick KM; Gieger TL; Williams LE; Ruslander DM; Northrup NC; Kristal O; Myers NC; Moore AS J Vet Intern Med; 2001; 15(3):196-9. PubMed ID: 11380027 [TBL] [Abstract][Full Text] [Related]
11. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma. Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727 [TBL] [Abstract][Full Text] [Related]
12. Risk factors associated with the onset of lomustine-induced neutropenia in tumour-bearing dogs. Treggiari E; Cossu G; Valenti P; Taylor A Vet Comp Oncol; 2022 Sep; 20(3):577-586. PubMed ID: 35249267 [TBL] [Abstract][Full Text] [Related]
13. Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012). Lejeune A; Skorupski K; Frazier S; Vanhaezebrouck I; Rebhun RB; Reilly CM; Rodriguez CO Vet Comp Oncol; 2015 Sep; 13(3):267-80. PubMed ID: 23721492 [TBL] [Abstract][Full Text] [Related]
14. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs. Flory AB; Rassnick KM; Al-Sarraf R; Bailey DB; Balkman CE; Kiselow MA; Autio K J Vet Intern Med; 2008; 22(1):164-71. PubMed ID: 18289305 [TBL] [Abstract][Full Text] [Related]
15. Tolerability of metronomic administration of lomustine in dogs with cancer. Tripp CD; Fidel J; Anderson CL; Patrick M; Pratt C; Sellon R; Bryan JN J Vet Intern Med; 2011; 25(2):278-84. PubMed ID: 21314727 [TBL] [Abstract][Full Text] [Related]
16. Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. Kristal O; Rassnick KM; Gliatto JM; Northrup NC; Chretin JD; Morrison-Collister K; Cotter SM; Moore AS J Vet Intern Med; 2004; 18(1):75-80. PubMed ID: 14765735 [TBL] [Abstract][Full Text] [Related]
17. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. Taylor F; Gear R; Hoather T; Dobson J J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421 [TBL] [Abstract][Full Text] [Related]
18. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic. Laprais A; Olivry T BMC Vet Res; 2017 Feb; 13(1):61. PubMed ID: 28222789 [TBL] [Abstract][Full Text] [Related]
19. CCNU for the treatment of dogs with histiocytic sarcoma. Skorupski KA; Clifford CA; Paoloni MC; Lara-Garcia A; Barber L; Kent MS; LeBlanc AK; Sabhlok A; Mauldin EA; Shofer FS; Couto CG; Sørenmo KU J Vet Intern Med; 2007; 21(1):121-6. PubMed ID: 17338159 [TBL] [Abstract][Full Text] [Related]
20. Lomustine for the treatment of gastrointestinal mast cell tumour in a dog. Baldi A; Colloca E; Spugnini EP J Small Anim Pract; 2006 Aug; 47(8):465-7. PubMed ID: 16911116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]